Get the Stockscreener App
7.1095
9.88%
0.6295
Inogen Inc stock is traded at $7.1095, with a volume of 267.81K.
It is up +9.88% in the last 24 hours and up +2.89% over the past month.
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
See More
Previous Close:
$6.48
Open:
$6.5
24h Volume:
267.81K
Relative Volume:
1.09
Market Cap:
$191.71M
Revenue:
$331.52M
Net Income/Loss:
$-52.69M
P/E Ratio:
-3.1598
EPS:
-2.25
Net Cash Flow:
$-14.47M
1W Performance:
+8.87%
1M Performance:
+2.89%
6M Performance:
-31.34%
1Y Performance:
-42.21%
1-Day Range:
$6.43
$7.38
1-Week Range:
$5.8502
$7.38
52-Week Range:
$5.70
$13.33
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
859 WARD DRIVE, GOLETA, CA
Compare INGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
7.13 | 169.39M | 331.52M | -52.69M | -14.47M | -2.25 |
|
ABT
Abbott Laboratories
|
131.25 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.84 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.20 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.78 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.16 | 46.15B | 5.69B | 4.14B | 577.90M | 6.96 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Initiated | B. Riley Securities | Buy |
| May-22-25 | Upgrade | Needham | Hold → Buy |
| Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-23 | Downgrade | Needham | Buy → Hold |
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Statistical indicators supporting Inogen Inc.’s strengthFree Daily Chart Pattern Stock Forecast - Newser
Is now a turning point for Inogen Inc.Forecasting Stock Moves with AI Insights - Newser
How to build a custom watchlist for Inogen Inc.Free Low Capital High Return Stock Plans - Newser
What indicators show strength in Inogen Inc.Free Buy Alerts With Low Risk Confirmation - Newser
Inogen Second Quarter 2025 Earnings: Beats Expectations - ca.finance.yahoo.com
Inogen Inc. stock prediction for this weekSummary of Trade Cycles in 5-Year Range - Newser
Live market analysis of Inogen Inc.Chart Driven Opportunity Scanner with Alerts - Newser
Tools to assess Inogen Inc.’s risk profileLong-Term Trend Tracking and Signal Summary - Newser
Why Inogen Inc. stock attracts strong analyst attentionConservative Investment Setup and Risk Analysis - Newser
Inogen's Q2 Earnings Beat: A Glimpse of Strategic Turnaround Amid Industry Headwinds? - AInvest
How Interest Rate Changes Impact Inogen Inc. Stock PerformanceShort Term Gain Strategy with AI Logic - Newser
Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y - MSN
Inogen's Q2 2025 Earnings and Strategic Product Innovation: A Pathway to Margin Expansion and Market Leadership - AInvest
How Inogen Inc. stock performs during market volatilityCapital Growth Summary Over Five Years - Newser
Can Inogen Catch Its Second Breath After An Upbeat Outlook? - RTTNews
Inogen Q2 2025 slides: B2B growth offsets consumer segment decline By Investing.com - Investing.com South Africa
Inogen Inc (INGN) Q2 2025 Earnings Call Highlights: Steady Growth Amidst Challenges - Yahoo Finance
Predicting Inogen Inc. trend using moving averagesFree Access to Real-Time Trade Insights - Newser
Inogen Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Inogen: Q2 Earnings Snapshot - Chron
Inogen reports Q2 EPS (15c), one estimate (9c) - TipRanks
What’s next for Inogen Inc. stock priceHistorical Stock Summary and ROI Review - Newser
Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Inogen's Turnaround Momentum and Path to EBITDA Breakeven in 2025 - AInvest
Inogen Inc earnings beat by $0.12, revenue topped estimates - Investing.com South Africa
Inogen Q2 revenue up 4%, beats estimates, raises FY revenue guidance - MarketScreener
Inogen Announces Second Quarter 2025 Financial Results - Yahoo Finance
Inogen Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Will Inogen Inc. stock recover after recent dropLong Hold Investment Strategy with Growth Focus - Newser
Developing predictive dashboards with Inogen Inc. dataInvestment Life Cycle Planning Summary - Newser
Inogen Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Early Entry Tips With Low Risk Zone - Newser
What catalysts could drive Inogen Inc. stock higher in 2025Breakneck growth rates - Jammu Links News
What is Inogen Inc. company’s growth strategyUnrivaled growth potential - Jammu Links News
What makes Inogen Inc. stock price move sharplyGrow your portfolio with growth-oriented stocks - Jammu Links News
How strong is Inogen Inc. company’s balance sheetMaximize portfolio growth with expert advice - Jammu Links News
What are the latest earnings results for Inogen Inc.Capitalize on market momentum for big wins - Jammu Links News
What technical models suggest about Inogen Inc.’s comebackAnnual Market Behavior and Sector Summary - Newser
Is Inogen Inc. a good long term investmentBreakneck growth rates - Jammu Links News
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Inogen Inc Stock (INGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 03 '25 |
Buy |
8.32 |
3,000 |
24,960 |
47,646 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '25 |
Option Exercise |
0.00 |
28,333 |
0 |
44,387 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 03 '25 |
Buy |
8.56 |
11,709 |
100,245 |
70,274 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '24 |
Option Exercise |
0.00 |
28,333 |
0 |
28,333 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '24 |
Option Exercise |
0.00 |
31,565 |
0 |
31,565 |
0.19%
1.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):